Very late isolated CNS relapse of acute myeloid leukemia

J Pediatr Hematol Oncol. 2013 Mar;35(2):e57-9. doi: 10.1097/MPH.0b013e318281e63b.

Abstract

Isolated central nervous system (CNS) relapse in acute myeloid leukemia (AML) rarely occurs later than 2 years after remission. We present a child diagnosed with AML (FAB M5) without CNS involvement at diagnosis who was treated with chemotherapy and consolidated with autologous hematopoietic stem cell transplantation. He was in complete remission for >6 years until he had an isolated CNS relapse. He was treated with only intrathecal chemotherapy and achieved a second complete remission, but relapsed in the bone marrow 5 months after the CNS relapse. Treatment of late isolated CNS relapse of AML is discussed.

Publication types

  • Case Reports

MeSH terms

  • CD56 Antigen / analysis
  • Central Nervous System Neoplasms / therapy*
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Infant
  • Leukemia, Myeloid, Acute / therapy*
  • Male
  • Recurrence
  • Time Factors
  • Transplantation, Autologous

Substances

  • CD56 Antigen
  • NCAM1 protein, human